Evommune (EVMN) vs SIGA Technologies (SIGA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
SIGA Technologies is the larger company by market cap ($234.2 million vs $225.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EVMN | SIGA |
|---|---|---|
| Share price | $6.22 | $3.26 |
| Market cap | $225.74M | $234.23M |
| 1-day change | -5.90% | -0.91% |
| YTD return | -63.67% | -46.64% |
| 1-year return | — | -61.37% |
| 5-year return | — | -54.15% |
| Forward P/E | — | 3.02 |
| EPS (TTM) | $-3.75 | $-0.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $33.20 | $8.55 |
| 52-week low | $6.08 | $2.83 |
| Distance from 52-week high | -81.27% | -61.87% |
| Analyst consensus | buy | none |
| Avg. price target upside | +287.94% | — |
| Average volume | 675.52K | 731.22K |
| Shares outstanding | 36.29M | 71.85M |
| Employees | 48 | 49 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Evommune
EVMN stock →Evommune, Inc. operates as a clinical-stage biotechnology company in the United States.
Healthcare · Biotechnology · 48 employees
About SIGA Technologies
SIGA stock →SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus.
Healthcare · Drug Manufacturers - Specialty & Generic · 49 employees
EVMN vs SIGA FAQ
Which is bigger, Evommune or SIGA Technologies?
SIGA Technologies (SIGA) is larger, with a market capitalization of $234.23M compared with $225.74M for Evommune (EVMN).
Are Evommune and SIGA Technologies in the same industry?
Both are in the Healthcare sector, but in different industries: Biotechnology for Evommune and Drug Manufacturers - Specialty & Generic for SIGA Technologies.